Use of Biomarkers to Assess Environmental Exposures and Health Outcomes in Deployed Troops.

J Occup Environ Med

Department of Preventive Medicine and Biostatistics, Uniformed Services University, Bethesda (Dr Mallon, Dr Krahl); Department of Environmental Medicine (Dr Woeller, Dr Hopke, Dr Utell); Pulmonary Division, Department of Medicine (Dr Thatcher, Dr Thakar, Dr Utell); Microbiology and Immunology (Dr Woeller); Department of Public Health Sciences (Dr Walker, Dr Smith, Dr Uppal, Dr Go, Dr Jones), Emory University, Atlanta, Georgia US Army Public Health Center, Edgewood (Dr Gaydos), Maryland; Medical Counter-CBRN and Environmental Health, Office of the Joint Staff Surgeon, The Pentagon, Washington DC (Mr Haines).

Published: December 2019

AI Article Synopsis

  • The Military Biomarkers Research Study (MBRS) aims to evaluate the use of biomarkers for assessing health impacts related to environmental exposures during military deployments.
  • The study is divided into four phases: feasibility of stored samples, exposure-biomarker associations, biomarker-health outcome relationships, and in vitro changes related to specific chemical exposures.
  • Key findings include the identification of new biomarkers linked to deployment exposures, with significant associations found between these biomarkers and health outcomes.

Article Abstract

Objective: This paper provides an overview of our Military Biomarkers Research Study (MBRS) designed to assess whether biomarkers can be used to retrospectively assess deployment exposures and health impacts related to deployment environmental exposures.

Methods: The MBRS consists of four phases. Phase I was a feasibility study of stored sera. Phase II looks at associations between exposures and biomarkers. Phase III examines relationships of biomarkers and health outcomes, and Phase IV investigates in vitro biomarker changes associated with exposures to chemicals of interest. This paper briefly summarizes work already published and introduces the new reports contained in this supplement.

Results: Novel biomarkers were identified. These were associated with deployment exposures.

Conclusions: Significant associations were noted between deployment exposures, microRNA biomarkers and metabolomic biomarkers, and deployment health outcomes.

Download full-text PDF

Source
http://dx.doi.org/10.1097/JOM.0000000000001752DOI Listing

Publication Analysis

Top Keywords

health outcomes
12
biomarkers
8
exposures health
8
deployment exposures
8
exposures
5
deployment
5
biomarkers assess
4
assess environmental
4
environmental exposures
4
health
4

Similar Publications

Enhancing farmer awareness: Vertical transmission of Neospora caninum in aborting cattle and the value of diagnostics tools.

Vet Parasitol

January 2025

Institute of Parasitology, Vetsuisse Faculty, University of Bern, Länggassstrasse 122, Bern 3012, Switzerland. Electronic address:

The protozoan parasite Neospora caninum is an important cause of abortion in cattle. Infection occurs horizontally by ingestion of oocysts shed by canids or vertically, from an infected dam to the foetus, and may result in abortion, stillbirth, or the birth of subclinically infected offspring. We estimated the occurrence of N.

View Article and Find Full Text PDF

Rural and remote health care: the case for spatial justice.

Rural Remote Health

January 2025

School of Health Sciences, Western Sydney University, Campbelltown, NSW 2560, Australia.

Almost universally, people living in rural and remote places die younger, poorer, and sicker than urban-dwelling citizens of the same country. Despite clear need, health services are commonly less available, and more costly and challenging to access, for rural and remote people. Rural geography is commonly cited as a reason for these disparities, that is, rural people are said to live in places too distant, too underpopulated, and too difficult to access.

View Article and Find Full Text PDF

Background: Prior studies indicate that 1% to 4% of Epstein-Barr virus (EBV)-seronegative recipients of EBV-seropositive donor (EBV D+/R-) kidneys develop posttransplant lymphoproliferative disorder (PTLD). However, these estimates are based on limited data that lack granularity.

Objective: To determine the associations between pretransplant EBV D+/R- and recipient EBV-seropositive status (R+) and the outcomes of PTLD and graft and patient survival among adult kidney transplant recipients.

View Article and Find Full Text PDF

Background: Real-world COVID-19 vaccine effectiveness (VE) studies are investigating exposures of increasing complexity accounting for time since vaccination. These studies require methods that adjust for the confounding that arises when morbidities and demographics are associated with vaccination and the risk of outcome events. Methods based on propensity scores (PS) are well-suited to this when the exposure is dichotomous, but present challenges when the exposure is multinomial.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!